Integrin α10β1-Selected Mesenchymal Stem Cells Reduce Pain and Cartilage Degradation and Increase Immunomodulation in an Equine Osteoarthritis Model

Researchers investigated disease-modifying effects of integrin α10-MSCs. They suggested that integrin α10-MSCs held promise as a disease-modifying osteoarthritis drug.